Treatment with CBD at 10-20 μM significantly downregulated key inflammatory genes, particularly COX-2, IL-6 and TNF-α, and reduced corresponding cytokine release without compromising cell viability.<h4>Conclusion</h4>The ECS is upregulated in CMC and appears to contribute to the inflammatory tumour microenvironment. Here, IL6 is linked to neoplasm.